secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K/A
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001213900-25-065728
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC issues 2.04M shares + 1M warrants for Taiwan land from director Shuling Jiang
--------------------------------------------------------------------------------

- Issued 2,035,136 restricted shares to Jiang for land valued at $3.86M, plus assumption of $500K bank liability.
- Warrant to purchase 1M shares at $2.50/share (cashless exercise); potential 5-year term.
- Separate consulting agreement grants 1M shares vesting 200K/yr over 5 years for land development services.
- Jiang's ownership could reach 23.3% of outstanding shares post-issuance and vesting (from current 8.16%).
- Reversion right if ABVC delists or change of control; price adjustment if stock falls below $1.65 before shares tradable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025065728/0001213900-25-065728-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025065728/ea0249475-8ka_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-065728

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer